| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer (NCT04505553) | University of Washington | 2021-06-01 |
| Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT05476380) | Tianjin Medical University Cancer Institute and Hospital | 2021-02-19 |
| Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer (NCT07182266) | Shanghai Zhongshan Hospital | 2021-01-04 |
| Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy (NCT07309991) | Sun Yat-sen University | 2021-01-01 |
| Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age (NCT06048913) | The First Affiliated Hospital with Nanjing Medical University | 2020-12-01 |
| National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401) | National Cancer Institute (NCI) | 2020-11-11 |
| Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . (NCT04652180) | Hospital Universitari de Bellvitge | 2020-11-06 |
| Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma (NCT05777707) | Beijing Friendship Hospital | 2020-10-29 |
| Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy (NCT04517019) | University Hospital Tuebingen | 2020-08-01 |
| Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19 (NCT07416825) | Institute of Oncology Ljubljana | 2020-01-01 |
| Yoga Program for Improving the Quality of Life in Couples Coping With Cancer (NCT04607590) | M.D. Anderson Cancer Center | 2019-05-31 |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers (NCT03948100) | M.D. Anderson Cancer Center | 2018-12-20 |
| Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (NCT03381651) | Zhejiang Cancer Hospital | 2018-02-22 |
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma (NCT03220009) | National Cancer Institute (NCI) | 2017-11-03 |
| Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy (NCT03094351) | Shanghai Chest Hospital | 2017-07-29 |
| Induction Chemotherapy for Locally Advanced Esophageal Cancer (NCT03110926) | University of Rochester | 2017-06-19 |
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors (NCT03507998) | Curegenix Inc. | 2017-06-17 |
| Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer (NCT03099382) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-05 |
| A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer (NCT03013712) | First Affiliated Hospital of Chengdu Medical College | 2017-01-01 |
| Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer (NCT02965976) | Roswell Park Cancer Institute | 2016-12-30 |
| Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180) (NCT02559687) | Merck Sharp & Dohme LLC | 2015-12-02 |
| Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) (NCT02564263) | Merck Sharp & Dohme LLC | 2015-12-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC） (NCT06828718) | Hebei Medical University Fourth Hospital | 2015-01-01 |
| Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer (NCT02527057) | Hunan Province Tumor Hospital | 2014-10-01 |
| Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer (NCT02355249) | Chinese Academy of Medical Sciences | 2014-09-01 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy (NCT02062632) | Mayo Clinic | 2014-04-14 |
| Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma (NCT02120911) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-01-01 |
| Comparable Study of Different Radiation Dose in Esophageal Carcinoma (NCT01937208) | Zhejiang Cancer Hospital | 2013-08-01 |
| Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer (NCT01691625) | Capital Medical University | 2012-09-01 |
| Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy (NCT01544790) | UMC Utrecht | 2012-04-01 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (NCT01262040) | Memorial Sloan Kettering Cancer Center | 2010-12-14 |
| Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia (NCT01097304) | National Cancer Institute (NCI) | 2010-04-01 |
| Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma (NCT02861690) | Sun Yat-sen University | 2010-01-01 |
| Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma (NCT01034683) | Taian Cancer Hospital | 2009-12-01 |
| Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy (NCT00636298) | Emory University | 2008-10-01 |
| Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction (NCT01766986) | Universitätsklinikum Hamburg-Eppendorf | 2008-01-01 |
| A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma (NCT00733889) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2006-12-01 |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy (NCT00991094) | M.D. Anderson Cancer Center | 2005-05-27 |
| Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. (NCT00590031) | Memorial Sloan Kettering Cancer Center | 2002-11-01 |
| Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma (NCT00176800) | University of Michigan Rogel Cancer Center | 2001-11-01 |